C. Arnett

发表

Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [18F]Fluorodeoxyglucose and [11C]Deoxyglucose

C. D. Arnett, A. Alavi, M. Reivich, 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET.

C. D. Arnett, A. Wolf, J. Fowler, 1987, Science.

Carbon-11 labelled ketamine-synthesis, distribution in mice and PET studies in baboons.

C. D. Arnett, A. Wolf, J. Fowler, 1997, Nuclear medicine and biology.

Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients

C. D. Arnett, J. Brodie, A. Wolf, 1988, Biological Psychiatry.

[11C]spiroperidol: synthesis, specific activity determination, and biodistribution in mice.

A. Wolf, J. Fowler, C. Arnett, 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Synthesis and biodistribution of 2-deoxy-2-[18F]fluoro-d-glucopyranosyl [18F]fluoride in mice

C. D. Arnett, A. Wolf, C. Arnett, 2004, European Journal of Nuclear Medicine.

Synthesis of 2-deoxy-2[82Br]bromo-d-mannose and related compounds and their biodistributions in mice

C. D. Arnett, A. Wolf, C. Arnett, 2004, European Journal of Nuclear Medicine.

Specific Binding of [11C]Spiroperidol in Rat Brain In Vivo

C. D. Arnett, A. Wolf, J. Fowler, 1983, Journal of neurochemistry.

Mapping brain neuroleptic receptors in the live baboon.

A. Wolf, J. Fowler, J. Logan, 1984, Biological psychiatry.

Subclassification of alpha-adrenergic receptors by direct binding studies.

C. D. Arnett, R. Lefkowitz, C. Arnett, 1979, Biochemical pharmacology.

Species differences in [11C]clorgyline binding in brain.

C. D. Arnett, N. Volkow, J. Fowler, 2001, Nuclear medicine and biology.

Turnover of Brain Monoamine Oxidase Measured In Vivo by Positron Emission Tomography Using l‐[11C]Deprenyl

C. D. Arnett, A. Wolf, B. Långström, 1987, Journal of neurochemistry.

Brain alpha-adrenergic receptors: comparison of [3H]WB 4101 binding with norepinephrine-stimulated cyclic AMP accumulation in rat cerebral cortex.

J. Davis, P. Skolnick, J. Daly, 1978, Brain research.

Syntheses and Specific Activity Determinations of No-Carrier-Added Fluorine-18-Labeled Neuroleptic Drugs

C. D. Arnett, A. Wolf, J. Fowler, 1985 .

Syntheses and specific activity determinations of no-carrier-added (NCA) F-18-labeled butyrophenone neuroleptics--benperidol, haloperidol, spiroperidol, and pipamperone.

A. Wolf, J. Fowler, C. Arnett, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A direct comparison of the brain uptake and plasma clearance of N-[11C]methylspiroperidol and [18F]N-methylspiroperidol in baboon using PET.

C. D. Arnett, A. Wolf, B. Långström, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

No-carrier-added fluorine-18-labeled N-methylspiroperidol: synthesis and biodistribution in mice.

C. D. Arnett, A. Wolf, J. Fowler, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Selective, irreversible in vivo binding of [11C]clorgyline and [11C]-L-deprenyl in mice: potential for measurement of functional monoamine oxidase activity in brain using positron emission tomography.

J S Fowler, R R MacGregor, C. D. Arnett, 1985, Biochemical pharmacology.

A simple one-pot synthesis of cyclopropane [11C]carbonyl chloride. Synthesis and biodistribution of [11C]cyclorphan†

C. D. Arnett, A. Wolf, D. Hwang, 1986 .

Denervation-induced changes in alpha and beta adrenergic receptors of the rat submandibular gland.

J. Davis, C. Arnett, 1979, Journal of Pharmacology and Experimental Therapeutics.

The utility of 1-[18F]fluoro-3-iodopropane for the synthesis of certain dopamine D-1 and benzodiazepine receptor radioligands.

C. D. Arnett, A. Wolf, C. Arnett, 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

No-carrier-added (NCA) (+/-)-N-(3-[18F]fluoropropyl)-N-normetazocine-synthesis and PET studies in a baboon.

A. Wolf, C. Arnett, C. Shiue, 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

A comparison of the brain uptake of N-(cyclopropyl[11C]methyl)norbuprenorphine ([11C]buprenorphine) and N-(cyclopropyl[11C]methyl)nordiprenorphine ([11C]diprenorphine) in baboon using PET.

A. Wolf, J. Fowler, J. Logan, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Brain α-adrenergic receptors: comparison of [3H]WB 4101 binding with norepinephrine-stimulated cyclic AMP accumulation in rat cerebral cortex

James N. Davis, C. D. Arnett, P. Skolnick, 1978, Brain Research.

Comparison of Three 18F‐Labeled Butyrophenone Neuroleptic Drugs in the Baboon Using Positron Emission Tomography

C. D. Arnett, A. Wolf, J. Fowler, 1985, Journal of neurochemistry.

[18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain.

J S Fowler, A. Wolf, J. Fowler, 1985, Life sciences.

Effects of DL-3-(5-benzimidazolyl)-2-methylalanine on brain and heart catecholamines-I. Depleting effects.

C. D. Arnett, C. Arnett, J. Wright, 1976, Biochemical pharmacology.

Synthesis and biodistribution of no-carrier-added [1-11C]putrescine.

N. Volkow, J. Brodie, A. Wolf, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The evaluation of the lumped constant for deoxyglucose and fluorodeoxyglucose in man

A. Alavi, M. Reivich, H. Atkins, 1984 .

Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET.

A. Wolf, J. Fowler, D. Christman, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.